Genome Canada’s Board of Directors welcomed three new members at its June 23, 2021 meeting.
Drawn from the academic, private and public sectors, Genome Canada Board Directors bring diverse experience and expertise to advance our mission to improve lives and strengthen communities through applied genomics research and innovation. Each Director is appointed for a two-year term, renewable up to a maximum of six years.
“We are thrilled to welcome three exceptional leaders to the Board as Genome Canada pursues a bold new strategic direction built on missions that generate solutions to today’s biggest global challenges.” – Dr. Elizabeth Douville, Chair of Genome Canada’s Board of Directors
“The breadth of experience Tracy, Ivo and Éliane bring to the table will help fuel Genome Canada’s impact in research and innovation to build stronger, healthier communities and drive environmental sustainability and prosperity. I’m privileged to work with such a skilled and dynamic Board of Directors.” – Dr. Rob Annan, President and CEO, Genome Canada